lobbying_activities: 3484205

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3484205	04a8f9a7-bbc6-4753-aedb-0f55a55970ab	Q4	BURRELL INTERNATIONAL GROUP LLC	401103483	TONIX PHARMACEUTICALS HOLDING CORP.	2025	fourth_quarter	PHA	LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY26 Defense Appropriation for broad-spectrum antivirals, FY26 LHHS for Long COVID and cocaine overdose funding; Alternative to Pain Act and Chronic Pain coverage	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2026-01-14T14:25:23-05:00